欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1152/001
药品名称Dutasteride/Tamsulosinhydrochloride Mylan
活性成分
    • Dutasteride 0.5 mg
    • Tamsulosin hydrochloride 0.4 mg
剂型Capsule, hard
上市许可持有人Mylan AB Box 23033 104 35 Stockholm Sweden
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Norway (NO)
    • Germany (DE)
      Dutasteride/Tamsulosin Mydutam 0.5 mg/0.4 mg Hartkapseln
    • Denmark (DK)
      Dutasterid/Tamsulosinhydrochloride Mylan
    • Belgium (BE)
      Dutasteride/Tamsulosine Viatris 0,5 mg/0,4 mg harde capsules
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Latvia (LV)
      Dutasteride/Tamsulosin Mylan 0,5 mg/0,4 mg cietās kapsulas
    • Lithuania (LT)
      Dutasteride/Tamsulosin Mylan 0,5 mg/0,4 mg kietosios kapsulės
    • Estonia (EE)
      DUTASTERIDE/TAMSULOSIN VIATRIS
    • Czechia (CZ)
      Taris
    • Romania (RO)
      Dutasterida/Tamsulosin Mydutam 0.5 mg/0.4 mg hard capsule
    • Croatia (HR)
      Vasgar 0,5 mg/0,4 mg tvrde kapsule
许可日期2019/08/14
最近更新日期2024/11/29
药物ATC编码
    • G04CA52 tamsulosin and dutasteride
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase